| VSMAX | VTSIX | VSMAX / VTSIX | |
| Total Expense Ratio | 0.05 | 0.03 | 167% |
| Annual Report Gross Expense Ratio | 0.05 | 0.03 | 167% |
| Fund Existence | 26 years | 27 years | - |
| Gain YTD | 18.382 | 22.571 | 81% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 3000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 183B | 11.2B | 1,634% |
| Annual Yield % from dividends | 1.21 | 1.22 | 100% |
| Returns for 1 year | 24.79 | 29.47 | 84% |
| Returns for 3 years | 58.30 | 52.15 | 112% |
| Returns for 5 years | 42.24 | 38.57 | 110% |
| Returns for 10 years | 157.13 | 145.81 | 108% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| DLHCX | 25.40 | 0.34 | +1.36% |
| Nomura Healthcare Fund Class C | |||
| MYICX | 11.70 | 0.10 | +0.86% |
| NYLI WMC International Research Eq Cl C | |||
| LAVSX | 17.70 | 0.11 | +0.63% |
| Lord Abbett Fundamental Equity R4 | |||
| RYCPX | 65.84 | 0.39 | +0.60% |
| Rydex Consumer Products C | |||
| ERSMX | 30.71 | 0.17 | +0.56% |
| Eaton Vance Atlanta Capital SMID-Cap R | |||